Skip to main content

Robert A. Screaton, PhD

Senior Scientist and Associate Professor at Sunnybrook Research Institute, University of Toronto

Location: Toronto Canada

Robert A. Screaton, PhD's expertise is in cell signaling, metabolism and cell death. He uses functional genomics approaches to identify novel components of signal transduction pathways and then develop and analyze pre-clinical models to study their roles in vivo. His group has established a high-throughput, robotic cell-based screening facility at the Children’s Hospital of Eastern Ontario Research Institute (CHEO-RI) with microplate imaging capacity, designed specifically to enable genome wide RNAi and overexpression screens. They have collaborated with local, national and international researchers to perform cell-based screens focused on mitochondrial function, with outcomes designed to improve understanding of the etiologies and treatment of Parkinson’s disease, diabetes and cancer.

Associated Grants

  • Mechanisms of Parkin Recruitment and Mitophagy


  • Functional Genomic Screening to Identify Novel Regulators of Parkin


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.